학술논문
Piperacillin-tazobactam should be preferred to third-generation cephalosporins to treat wild-type inducible AmpC-producing Enterobacterales in critically ill patients with hospital or ventilator-acquired pneumonia
Document Type
Article
Author
Source
In Journal of Critical Care April 2020 56:6-11
Subject
Language
ISSN
0883-9441